Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Sublease Agreement (Tables)

3 Months Ended

Mar. 31, 2015

The changes in the liability related to the sublease agreement for the three months ended March 31, 2015 were as follows (in thousands):

Balance at January 1, 2015	$	9,269
Accretion of deferred liability	158
Amortization of deferred liability	(841)
Balance at March 31, 2015	$	8,586